Association between left ventricular reverse remodeling and long-term outcomes after alcohol septal ablation for

Fu-Jian Duan1, You-Zhou Chen2, Jian-Song Yuan3

  • 1Department of Echocardiography, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences, Peking Union Medical College, Being, People's Republic of China.

Insights

Left ventricular reverse remodeling (r-LVR) after alcohol septal ablation (ASA) improves diastolic function and outcomes in hypertrophic obstructive cardiomyopathy (HOCM). Higher baseline left ventricular mass (LVM) predicts less r-LVR and poorer diastolic function post-ASA.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Interventional Cardiology

Background:

  • Hypertrophic obstructive cardiomyopathy (HOCM) presents challenges in managing left ventricular (LV) diastolic dysfunction.
  • Alcohol septal ablation (ASA) is a treatment option for HOCM, but its impact on LV reverse remodeling (r-LVR) and diastolic function requires further investigation.

Purpose of the Study:

  • To assess the effect of r-LVR on diastolic function and clinical outcomes following ASA in HOCM patients.
  • To identify predictors of r-LVR after ASA.

Main Methods:

  • Eighty-seven HOCM patients underwent echocardiography and cardiovascular magnetic resonance (CMR) imaging at baseline and 27 months post-ASA.
  • Patients were stratified into groups based on the degree of r-LVR.
  • Kaplan-Meier analysis and multivariable regression were used to evaluate outcomes and predictors.

Main Results:

  • Greater r-LVR correlated with significant LV mass regression and improved diastolic function (E/e') post-ASA.
  • Patients with lesser r-LVR experienced worse composite clinical events.
  • Preablation LV mass (LVM) was associated with a decreased likelihood of r-LVR and less diastolic function improvement.

Conclusions:

  • r-LVR is associated with improved long-term outcomes and diastolic function in HOCM patients treated with ASA.
  • Preablation LVM may hinder reverse remodeling, suggesting its potential role in risk stratification and prognosis after ASA.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
27
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
37
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
32
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
31
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
20
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
22